{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:21:35Z","timestamp":1781662895320,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.vascn.2008.01.002","type":"journal-article","created":{"date-parts":[[2008,2,8]],"date-time":"2008-02-08T10:12:59Z","timestamp":1202465579000},"page":"155-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Development of a simplified assay for determination of the antimineralocorticoid activity of compounds dosed in rats"],"prefix":"10.1016","volume":"57","author":[{"given":"Philip E.","family":"Brandish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Szczerba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Hershey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2008.01.002_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0163-7258(99)00038-8","article-title":"General overview of mineralocorticoid hormone action","volume":"84","author":"Agarwal","year":"1999","journal-title":"Pharmacoogy & Therapeutics"},{"key":"10.1016\/j.vascn.2008.01.002_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev.physiol.62.1.573","article-title":"Structure and regulation of amiloride-sensitive sodium channels","volume":"62","author":"Alvarez","year":"2000","journal-title":"Annual Review of Physiology"},{"key":"10.1016\/j.vascn.2008.01.002_bib3","doi-asserted-by":"crossref","first-page":"9424","DOI":"10.1073\/pnas.95.16.9424","article-title":"Mineralocorticoid receptor knockout mice: Pathophysiology of Na+ metabolism","volume":"95","author":"Berger","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.vascn.2008.01.002_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tem.2004.03.009","article-title":"Mechanisms of mineralocorticoid action: Determinants of receptor specificity and actions of regulated gene products","volume":"15","author":"Bhargava","year":"2004","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"N3","key":"10.1016\/j.vascn.2008.01.002_bib5","first-page":"432","article-title":"Antihypertensive and renoprotective effects of eplerenone in Dahl salt-sensitive rats","volume":"42","author":"Blasi","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.vascn.2008.01.002_bib6","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney International"},{"key":"10.1016\/j.vascn.2008.01.002_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.1.06017","article-title":"The new biology of aldosterone","volume":"186","author":"Connell","year":"2005","journal-title":"The Journal of Endocrinology"},{"key":"10.1016\/j.vascn.2008.01.002_bib8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","article-title":"Three new epoxy-spirolactone derivatives: Characterization in vivo and in vitro","volume":"240","author":"de Gasparo","year":"1987","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2008.01.002_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJMp048132","article-title":"Aldosterone\u2014Villain or bystander?","volume":"351","author":"Dluhy","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.vascn.2008.01.002_bib10","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1210\/endo.142.8.8339","article-title":"Experimental cardiac fibrosis: Differential time course of responses to mineralocorticoid-salt administration","volume":"142","author":"Fujisawa","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.vascn.2008.01.002_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1126\/science.289.5476.119","article-title":"Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy","volume":"289","author":"Geller","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.vascn.2008.01.002_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00041552-200403000-00007","article-title":"Brain mineralocorticoid receptors: Orchestrators of hypertension and end-organ disease","volume":"13","author":"Gomez-Sanchez","year":"2004","journal-title":"Current Opinion in Nephrology and Hypertension"},{"key":"10.1016\/j.vascn.2008.01.002_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3181\/00379727-104-25726","article-title":"Mineralocorticoid effects of 9 alphafluorodeoxycorticosterone in adrenalectomized rats","volume":"104","author":"Kagawa","year":"1960","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"key":"10.1016\/j.vascn.2008.01.002_bib14","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1046\/j.1523-1755.2000.00055.x","article-title":"Effects of spironolactone on systolic blood pressure in experimental diabetic rats","volume":"57","author":"Liu","year":"2000","journal-title":"Kidney International"},{"key":"10.1016\/j.vascn.2008.01.002_bib15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0026-0495(79)90201-4","article-title":"Mineralocorticoid-induced blood pressure, electrolyte, and hormone changes, and reversal with spironolactone, in healthy men","volume":"28","author":"Nicholls","year":"1979","journal-title":"Metabolism"},{"key":"10.1016\/j.vascn.2008.01.002_bib16","doi-asserted-by":"crossref","first-page":"36863","DOI":"10.1074\/jbc.R100047200","article-title":"Nuclear receptor minireview series","volume":"276","author":"Olefsky","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.vascn.2008.01.002_bib17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"The New England Journal of Medicine"},{"issue":"Suppl G:2\u20134","key":"10.1016\/j.vascn.2008.01.002_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/eurheartj\/13.suppl_G.2","article-title":"Comparative mechanisms of action of diuretic drugs in hypertension","volume":"13","author":"van Zwieten","year":"1992","journal-title":"European Heart Journal"},{"key":"10.1016\/j.vascn.2008.01.002_bib19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.vascn.2008.01.002_bib20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"American Journal of Hypertension"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871908000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871908000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T23:53:28Z","timestamp":1761004408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871908000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1056871908000087"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2008.01.002","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a simplified assay for determination of the antimineralocorticoid activity of compounds dosed in rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2008.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}